IMNM – immunome, inc. (US:NASDAQ)
Stock Stats
News
Immunome to Present at 2024 Bank of America Healthcare Conference
Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Progress [Yahoo! Finance]
Immunome Appoints Kinney Horn as Chief Business Officer [Yahoo! Finance]
Immunome Appoints Kinney Horn as Chief Business Officer
Immunome, Inc. (NASDAQ: IMNM) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $24.00 price target on the stock.
Form 8-K Immunome Inc. For: Apr 24
Form 4 Immunome Inc. For: Apr 25 Filed by: SWAIN SANDRA M
Form 3 Immunome Inc. For: Apr 25 Filed by: SWAIN SANDRA M
Form ARS Immunome Inc. For: Dec 31
Form DEFA14A Immunome Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.